Xcout Intel
TATUM Bioscience
TATUM Bioscience is a biotechnology research company headquartered in Sherbrooke, Canada, pioneering nanofilament immunotherapy for cancer treatment. Their breakthrough technology is designed to boost tumor visibility and restore anti-tumor immune responses.
Subscribe to see TATUM Bioscience’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TATUM Bioscience at a glance
TATUM Bioscience is a biotechnology company headquartered in Canada. Xcout tracks 10 named people at TATUM Bioscience, including Véronique Riethuisen (CFO).
TATUM Bioscience leadership
- Véronique RiethuisenCFO
- Alexandre LebeautCMO
- Jean-François MillauCEO and co-founder
- Kevin NeilCSO and co-founder
- Sébastien RodrigueCo-founder and Special Scientific Advisor
- Jean-François MillauCEO TATUM bioscience
4 more named people on record for TATUM Bioscience, with roles, board committees and tenure — see the full roster →
TATUM Bioscience competitors
A few of TATUM Bioscience's closest competitors — see the full list of competitors and alternatives →
Immugenia Inc. is a preclinical-stage immuno-oncology company located in Sherbrooke, Quebec, Canada, developing next-generation CAR therapies by engineering hematopoietic stem cells to treat and prevent cancer relapses.
Defence Therapeutics is a publicly traded Canadian biotechnology company headquartered in Montreal, Quebec. It is a precision intracellular drug-delivery company focused on unlocking the full potential of cancer biologics.
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
Lurex Bio is an early-stage biotechnology research company developing a therapeutic platform designed to help the immune system recognize immune-cold solid tumors, such as MSS colorectal and pancreatic cancers. The company's proposed approach aims to mark tumor surfaces with synthetic recognition signals to make them more targetable by downstream immunotherapies.
Reverb Therapeutics is a biotechnology research company headquartered in Vancouver, British Columbia. The company focuses on cancer therapeutics by developing its proprietary Amplify-R platform designed to intelligently adjust and tune the body's natural immune system.
ImmunityBio, Inc. is a public clinical-stage immunotherapy company headquartered in San Diego, California. As a member of the NantWorks ecosystem, it focuses on developing next-generation cancer vaccines and immunotherapies.
Get TATUM Bioscience's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on TATUM Bioscience in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access